{"id":5816,"date":"2023-12-17T05:20:39","date_gmt":"2023-12-17T05:20:39","guid":{"rendered":"https:\/\/blogs.sld.cu\/oserranob\/?p=5816"},"modified":"2023-12-18T18:27:42","modified_gmt":"2023-12-18T18:27:42","slug":"expectativas-por-aprobacion-de-la-edicion-del-genoma-como-terapia-en-humanos","status":"publish","type":"post","link":"https:\/\/blogs.sld.cu\/oserranob\/2023\/12\/17\/expectativas-por-aprobacion-de-la-edicion-del-genoma-como-terapia-en-humanos\/","title":{"rendered":"Expectativas por aprobaci\u00f3n de la edici\u00f3n del genoma como terapia en humanos"},"content":{"rendered":"<p><a href=\"https:\/\/blogs.sld.cu\/oserranob\/files\/2023\/12\/231217_CRISPR.jpg\"><img loading=\"lazy\" class=\"alignleft wp-image-5830 size-full\" title=\"(c) Ledford H. Nature, 2023.\" src=\"https:\/\/blogs.sld.cu\/oserranob\/files\/2023\/12\/231217_CRISPR.jpg\" alt=\"\" width=\"150\" height=\"85\" \/><\/a>Considerada una &#8220;primera generaci\u00f3n de terapias de edici\u00f3n del genoma&#8221;, el uso de CRISPR-Cas9 en enfermedades humanas <a href=\"https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-gene-therapies-treat-patients-sickle-cell-disease\">ya ha sido aprobado<\/a>. La pr\u00f3xima generaci\u00f3n de t\u00e9cnicas de edici\u00f3n es comentada en Ledford H. <a href=\"https:\/\/www.nature.com\/articles\/d41586-023-03797-7\">CRISPR 2.0: a new wave of gene editors heads for clinical trials<\/a>. Nature, 2023; doi: https:\/\/doi.org\/10.1038\/d41586-023-03797-7.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Considerada una &#8220;primera generaci\u00f3n de terapias de edici\u00f3n del genoma&#8221;, el uso de CRISPR-Cas9 en enfermedades humanas ya ha sido aprobado. La pr\u00f3xima generaci\u00f3n de t\u00e9cnicas de edici\u00f3n es comentada en Ledford H. CRISPR 2.0: a new wave of gene editors heads for clinical trials. Nature, 2023; doi: https:\/\/doi.org\/10.1038\/d41586-023-03797-7.<\/p>\n","protected":false},"author":125,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[44,32],"tags":[],"_links":{"self":[{"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/posts\/5816"}],"collection":[{"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/users\/125"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/comments?post=5816"}],"version-history":[{"count":3,"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/posts\/5816\/revisions"}],"predecessor-version":[{"id":5832,"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/posts\/5816\/revisions\/5832"}],"wp:attachment":[{"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/media?parent=5816"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/categories?post=5816"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.sld.cu\/oserranob\/wp-json\/wp\/v2\/tags?post=5816"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}